ID ERBB3_MOUSE Reviewed; 1339 AA. AC Q61526; Q3KQR1; Q68J64; Q810U8; Q8K317; DT 15-DEC-1998, integrated into UniProtKB/Swiss-Prot. DT 11-OCT-2005, sequence version 2. DT 27-MAR-2024, entry version 193. DE RecName: Full=Receptor tyrosine-protein kinase erbB-3; DE EC=2.7.10.1; DE AltName: Full=Glial growth factor receptor; DE AltName: Full=Proto-oncogene-like protein c-ErbB-3; DE Flags: Precursor; GN Name=Erbb3; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RC STRAIN=BALB/cJ; RA Yamauchi J., Shooter E.M.; RT "Involvement of the ErbB3 signaling pathway in Schwann cell migration."; RL Submitted (JUL-2004) to the EMBL/GenBank/DDBJ databases. RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=FVB/N; TISSUE=Mammary tumor, and Thyroid; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [3] RP NUCLEOTIDE SEQUENCE [MRNA] OF 1061-1154. RC TISSUE=Muscle fibroblast; RX PubMed=7589796; DOI=10.1006/dbio.1995.0012; RA Moscoso L.M., Chu G.C., Gautam M., Noakes P.G., Merlie J.P., Sanes J.R.; RT "Synapse-associated expression of an acetylcholine receptor-inducing RT protein, ARIA/heregulin, and its putative receptors, ErbB2 and ErbB3, in RT developing mammalian muscle."; RL Dev. Biol. 172:158-169(1995). RN [4] RP INTERACTION WITH MYOC. RX PubMed=23897819; DOI=10.1074/jbc.m112.446138; RA Kwon H.S., Johnson T.V., Joe M.K., Abu-Asab M., Zhang J., Chan C.C., RA Tomarev S.I.; RT "Myocilin mediates myelination in the peripheral nervous system through RT ErbB2/3 signaling."; RL J. Biol. Chem. 288:26357-26371(2013). CC -!- FUNCTION: Tyrosine-protein kinase that plays an essential role as cell CC surface receptor for neuregulins. Binds to neuregulin-1 (NRG1) and is CC activated by it; ligand-binding increases phosphorylation on tyrosine CC residues and promotes its association with the p85 subunit of CC phosphatidylinositol 3-kinase. May also be activated by CSPG5. Involved CC in the regulation of myeloid cell differentiation. CC {ECO:0000250|UniProtKB:P21860}. CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl- CC [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA- CC COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858, CC ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.1; CC Evidence={ECO:0000255|PROSITE-ProRule:PRU10028}; CC -!- SUBUNIT: Monomer and homodimer. Heterodimer with each of the other ERBB CC receptors (Potential). Interacts with CSPG5, PA2G4, GRB7 and MUC1 (By CC similarity). Interacts with MYOC (PubMed:23897819). Found in a ternary CC complex with NRG1 and ITGAV:ITGB3 or ITGA6:ITGB4 (By similarity). CC {ECO:0000250|UniProtKB:P21860, ECO:0000269|PubMed:23897819, CC ECO:0000305}. CC -!- INTERACTION: CC Q61526; P70424: Erbb2; NbExp=2; IntAct=EBI-931878, EBI-2945468; CC -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Single-pass type I CC membrane protein {ECO:0000250}. CC -!- TISSUE SPECIFICITY: In the muscle, expression localizes to the synaptic CC sites of muscle fibers. CC -!- DOMAIN: The cytoplasmic part of the receptor may interact with the SH2 CC or SH3 domains of many signal-transducing proteins. CC -!- PTM: Autophosphorylated. Ligand-binding increases phosphorylation on CC tyrosine residues and promotes its association with the p85 subunit of CC phosphatidylinositol 3-kinase. {ECO:0000250|UniProtKB:P21860}. CC -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein CC kinase family. EGF receptor subfamily. {ECO:0000255|PROSITE- CC ProRule:PRU00159}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AY686636; AAT95433.1; -; mRNA. DR EMBL; BC029028; AAH29028.1; -; mRNA. DR EMBL; BC049279; AAH49279.1; -; mRNA. DR EMBL; BC106091; AAI06092.1; -; mRNA. DR EMBL; L47240; AAA93533.1; -; mRNA. DR CCDS; CCDS24283.1; -. DR RefSeq; NP_034283.1; NM_010153.1. DR AlphaFoldDB; Q61526; -. DR SMR; Q61526; -. DR BioGRID; 199497; 26. DR IntAct; Q61526; 2. DR STRING; 10090.ENSMUSP00000080716; -. DR GlyConnect; 2676; 3 N-Linked glycans (1 site). DR GlyCosmos; Q61526; 10 sites, 3 glycans. DR GlyGen; Q61526; 10 sites, 3 N-linked glycans (1 site). DR iPTMnet; Q61526; -. DR PhosphoSitePlus; Q61526; -. DR MaxQB; Q61526; -. DR PaxDb; 10090-ENSMUSP00000080716; -. DR PeptideAtlas; Q61526; -. DR ProteomicsDB; 275878; -. DR ABCD; Q61526; 1 sequenced antibody. DR Antibodypedia; 3428; 2987 antibodies from 53 providers. DR DNASU; 13867; -. DR Ensembl; ENSMUST00000082059.7; ENSMUSP00000080716.7; ENSMUSG00000018166.9. DR GeneID; 13867; -. DR KEGG; mmu:13867; -. DR UCSC; uc007hnm.1; mouse. DR AGR; MGI:95411; -. DR CTD; 2065; -. DR MGI; MGI:95411; Erbb3. DR VEuPathDB; HostDB:ENSMUSG00000018166; -. DR eggNOG; KOG1025; Eukaryota. DR GeneTree; ENSGT00940000156107; -. DR HOGENOM; CLU_003384_2_0_1; -. DR InParanoid; Q61526; -. DR OMA; PDPNQCC; -. DR OrthoDB; 1614410at2759; -. DR PhylomeDB; Q61526; -. DR TreeFam; TF106002; -. DR BRENDA; 2.7.10.1; 3474. DR Reactome; R-MMU-1227986; Signaling by ERBB2. DR Reactome; R-MMU-1236394; Signaling by ERBB4. DR Reactome; R-MMU-1250196; SHC1 events in ERBB2 signaling. DR Reactome; R-MMU-1257604; PIP3 activates AKT signaling. DR Reactome; R-MMU-1306955; GRB7 events in ERBB2 signaling. DR Reactome; R-MMU-1358803; Downregulation of ERBB2:ERBB3 signaling. DR Reactome; R-MMU-1963642; PI3K events in ERBB2 signaling. DR Reactome; R-MMU-5673001; RAF/MAP kinase cascade. DR Reactome; R-MMU-6785631; ERBB2 Regulates Cell Motility. DR Reactome; R-MMU-6811558; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling. DR Reactome; R-MMU-8847993; ERBB2 Activates PTK6 Signaling. DR Reactome; R-MMU-8863795; Downregulation of ERBB2 signaling. DR BioGRID-ORCS; 13867; 2 hits in 80 CRISPR screens. DR ChiTaRS; Erbb3; mouse. DR PRO; PR:Q61526; -. DR Proteomes; UP000000589; Chromosome 10. DR RNAct; Q61526; Protein. DR Bgee; ENSMUSG00000018166; Expressed in small intestine Peyer's patch and 266 other cell types or tissues. DR GO; GO:0016324; C:apical plasma membrane; IDA:MGI. DR GO; GO:0009925; C:basal plasma membrane; IBA:GO_Central. DR GO; GO:0016323; C:basolateral plasma membrane; ISO:MGI. DR GO; GO:0038143; C:ERBB3:ERBB2 complex; ISO:MGI. DR GO; GO:0005615; C:extracellular space; ISO:MGI. DR GO; GO:0016328; C:lateral plasma membrane; IDA:MGI. DR GO; GO:0005886; C:plasma membrane; IDA:MGI. DR GO; GO:0045211; C:postsynaptic membrane; ISO:MGI. DR GO; GO:0043235; C:receptor complex; ISO:MGI. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW. DR GO; GO:0043125; F:ErbB-3 class receptor binding; ISO:MGI. DR GO; GO:0019838; F:growth factor binding; ISO:MGI. DR GO; GO:0042802; F:identical protein binding; ISO:MGI. DR GO; GO:0038132; F:neuregulin binding; ISS:UniProtKB. DR GO; GO:0038131; F:neuregulin receptor activity; IMP:MGI. DR GO; GO:0046982; F:protein heterodimerization activity; ISO:MGI. DR GO; GO:0004672; F:protein kinase activity; IEA:InterPro. DR GO; GO:0030296; F:protein tyrosine kinase activator activity; ISO:MGI. DR GO; GO:0038023; F:signaling receptor activity; IDA:MGI. DR GO; GO:0004888; F:transmembrane signaling receptor activity; IDA:MGI. DR GO; GO:0031625; F:ubiquitin protein ligase binding; ISO:MGI. DR GO; GO:0021545; P:cranial nerve development; IMP:MGI. DR GO; GO:0003197; P:endocardial cushion development; IMP:MGI. DR GO; GO:0007173; P:epidermal growth factor receptor signaling pathway; ISO:MGI. DR GO; GO:0038133; P:ERBB2-ERBB3 signaling pathway; IDA:MGI. DR GO; GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; ISO:MGI. DR GO; GO:0097049; P:motor neuron apoptotic process; IMP:MGI. DR GO; GO:0042552; P:myelination; IMP:MGI. DR GO; GO:0043066; P:negative regulation of apoptotic process; IBA:GO_Central. DR GO; GO:0007162; P:negative regulation of cell adhesion; ISO:MGI. DR GO; GO:2000672; P:negative regulation of motor neuron apoptotic process; IMP:MGI. DR GO; GO:0043524; P:negative regulation of neuron apoptotic process; IMP:MGI. DR GO; GO:0051048; P:negative regulation of secretion; ISO:MGI. DR GO; GO:0009968; P:negative regulation of signal transduction; ISO:MGI. DR GO; GO:0022008; P:neurogenesis; IBA:GO_Central. DR GO; GO:0051402; P:neuron apoptotic process; IMP:MGI. DR GO; GO:0007422; P:peripheral nervous system development; IMP:MGI. DR GO; GO:0043491; P:phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISO:MGI. DR GO; GO:0016310; P:phosphorylation; IEA:UniProtKB-KW. DR GO; GO:0070886; P:positive regulation of calcineurin-NFAT signaling cascade; IGI:MGI. DR GO; GO:0055025; P:positive regulation of cardiac muscle tissue development; IMP:MGI. DR GO; GO:0008284; P:positive regulation of cell population proliferation; IBA:GO_Central. DR GO; GO:0010628; P:positive regulation of gene expression; IMP:MGI. DR GO; GO:0046326; P:positive regulation of glucose import; ISO:MGI. DR GO; GO:0042127; P:regulation of cell population proliferation; ISO:MGI. DR GO; GO:0014044; P:Schwann cell development; IMP:MGI. DR GO; GO:0014037; P:Schwann cell differentiation; IMP:MGI. DR GO; GO:0007165; P:signal transduction; ISO:MGI. DR GO; GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; ISO:MGI. DR CDD; cd00064; FU; 3. DR CDD; cd12095; TM_ErbB3; 1. DR Gene3D; 1.20.890.10; cAMP-dependent protein kinase regulatory subunit, dimerization-anchoring domain; 1. DR Gene3D; 3.80.20.20; Receptor L-domain; 2. DR Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1. DR InterPro; IPR006211; Furin-like_Cys-rich_dom. DR InterPro; IPR006212; Furin_repeat. DR InterPro; IPR032778; GF_recep_IV. DR InterPro; IPR009030; Growth_fac_rcpt_cys_sf. DR InterPro; IPR011009; Kinase-like_dom_sf. DR InterPro; IPR000719; Prot_kinase_dom. DR InterPro; IPR000494; Rcpt_L-dom. DR InterPro; IPR036941; Rcpt_L-dom_sf. DR InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom. DR InterPro; IPR008266; Tyr_kinase_AS. DR InterPro; IPR020635; Tyr_kinase_cat_dom. DR InterPro; IPR016245; Tyr_kinase_EGF/ERB/XmrK_rcpt. DR PANTHER; PTHR24416:SF88; RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3; 1. DR PANTHER; PTHR24416; TYROSINE-PROTEIN KINASE RECEPTOR; 1. DR Pfam; PF00757; Furin-like; 1. DR Pfam; PF14843; GF_recep_IV; 1. DR Pfam; PF07714; PK_Tyr_Ser-Thr; 1. DR Pfam; PF01030; Recep_L_domain; 2. DR PIRSF; PIRSF000619; TyrPK_EGF-R; 1. DR PRINTS; PR00109; TYRKINASE. DR SMART; SM00261; FU; 5. DR SMART; SM00219; TyrKc; 1. DR SUPFAM; SSF57184; Growth factor receptor domain; 2. DR SUPFAM; SSF52058; L domain-like; 2. DR SUPFAM; SSF56112; Protein kinase-like (PK-like); 1. DR PROSITE; PS50011; PROTEIN_KINASE_DOM; 1. DR PROSITE; PS00109; PROTEIN_KINASE_TYR; 1. DR Genevisible; Q61526; MM. PE 1: Evidence at protein level; KW ATP-binding; Disulfide bond; Glycoprotein; Kinase; Membrane; KW Nucleotide-binding; Phosphoprotein; Receptor; Reference proteome; Signal; KW Transferase; Transmembrane; Transmembrane helix; Tyrosine-protein kinase. FT SIGNAL 1..19 FT /evidence="ECO:0000255" FT CHAIN 20..1339 FT /note="Receptor tyrosine-protein kinase erbB-3" FT /id="PRO_0000042231" FT TOPO_DOM 20..641 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 642..662 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 663..1339 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT DOMAIN 707..964 FT /note="Protein kinase" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159" FT REGION 1028..1052 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1077..1156 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1181..1212 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 1086..1100 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 1108..1129 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT ACT_SITE 832 FT /note="Proton acceptor" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159, FT ECO:0000255|PROSITE-ProRule:PRU10028" FT BINDING 713..721 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159" FT BINDING 740 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159" FT BINDING 786..788 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159" FT BINDING 832..837 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159" FT MOD_RES 684 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P21860" FT MOD_RES 980 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P21860" FT CARBOHYD 126 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 250 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 353 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 408 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 414 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 437 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 469 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 522 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 566 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 616 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 186..194 FT /evidence="ECO:0000250|UniProtKB:P21860" FT DISULFID 190..202 FT /evidence="ECO:0000250|UniProtKB:P21860" FT DISULFID 210..218 FT /evidence="ECO:0000250|UniProtKB:P21860" FT DISULFID 214..226 FT /evidence="ECO:0000250|UniProtKB:P21860" FT DISULFID 227..235 FT /evidence="ECO:0000250|UniProtKB:P21860" FT DISULFID 231..243 FT /evidence="ECO:0000250|UniProtKB:P21860" FT DISULFID 246..255 FT /evidence="ECO:0000250|UniProtKB:P21860" FT DISULFID 259..286 FT /evidence="ECO:0000250|UniProtKB:P21860" FT DISULFID 290..301 FT /evidence="ECO:0000250|UniProtKB:P21860" FT DISULFID 305..320 FT /evidence="ECO:0000250|UniProtKB:P21860" FT DISULFID 323..327 FT /evidence="ECO:0000250|UniProtKB:P21860" FT DISULFID 500..509 FT /evidence="ECO:0000250|UniProtKB:P21860" FT DISULFID 504..517 FT /evidence="ECO:0000250|UniProtKB:P21860" FT DISULFID 520..529 FT /evidence="ECO:0000250|UniProtKB:P21860" FT DISULFID 533..549 FT /evidence="ECO:0000250|UniProtKB:P21860" FT DISULFID 552..565 FT /evidence="ECO:0000250|UniProtKB:P21860" FT DISULFID 556..573 FT /evidence="ECO:0000250|UniProtKB:P21860" FT DISULFID 576..585 FT /evidence="ECO:0000250|UniProtKB:P21860" FT DISULFID 589..610 FT /evidence="ECO:0000250|UniProtKB:P21860" FT DISULFID 613..621 FT /evidence="ECO:0000250|UniProtKB:P21860" FT DISULFID 617..629 FT /evidence="ECO:0000250|UniProtKB:P21860" FT CONFLICT 1067 FT /note="A -> V (in Ref. 3; AAA93533)" FT /evidence="ECO:0000305" SQ SEQUENCE 1339 AA; 147613 MW; 59D56FD9C9536FBE CRC64; MSAIGTLQVL GFLLSLARGS EMGNSQAVCP GTLNGLSVTG DADNQYQTLY KLYEKCEVVM GNLEIVLTGH NADLSFLQWI REVTGYVLVA MNEFSVLPLP NLRVVRGTQV YDGKFAIFVM LNYNTNSSHA LRQLRFTQLT EILLGGVYIE KNDKLCHMDT IDWRDIVRVP DAEIVVKNNG GNCPPCHEVC KGRCWGPGPE DCQILTKTIC APQCNGRCFG PNPNQCCHDE CAGGCSGPQD TDCFACRHFN DSGACVPRCP APLVYNKLTF QLEPNPHIKY QYGGVCVASC PHNFVVDQTF CVRACPADKM EVDKNGLKMC EPCRGLCPKA CEGTGSGSRY QTVDSSNIDG FVNCTKILGN LDFLITGLNG DPWHKIPALD PEKLNVFRTV REITGYLNIQ SWPPHMHNFS VFSNLTTIGG RSLYNRGFSL LIMKNLNVTS LGFRSLKEIS AGRVYISANQ QLCYHHSLNW TRLLRGPAEE RLDIKYNRPL GECVAEGKVC DPLCSSGGCW GPGPGQCLSC RNYSREGVCV THCNVLQGEP REFVHEAHCF SCHPECQPME GTSTCNGSGS DACARCAHFR DGPHCVNSCP HGILGAKGPI YKYPDAQNEC RPCHENCTQG CKGPELQDCL GQAEVLMSKP HLVIAVTVGL TVIFLILGGS FLYWRGRRIQ NKRAMRRYLE RGESIEPLDP SEKANKVLAR IFKETELRKL KVLGSGVFGT VHKGIWIPEG ESIKIPVCIK VIEDKSGRQS FQAVTDHMLA VGSLDHAHIV RLLGLCPGSS LQLVTQYLPL GSLLDHVRQH RETLGPQLLL NWGVQIAKGM YYLEEHSMVH RDLALRNVML KSPSQVQVAD FGVADLLPPD DKQLLHSEAK TPIKWMALES IHFGKYTHQS DVWSYGVTVW ELMTFGAEPY AGLRLAEIPD LLEKGERLAQ PQICTIDVYM VMVKCWMIDE NIRPTFKELA NEFTRMARDP PRYLVIKRAS GPGIPPAAEP SALSTKELQD AELEPDLDLD LDVEVEEEGL ATTLGSALSL PTGTLTRPRG SQSLLSPSSG YMPMNQSNLG EACLDSAVLG GREQFSRPIS LHPIPRGRQT SESSEGHVTG SEAELQERVS MCRSRSRSRS PRPRGDSAYH SQRHSLLTPV TPLSPPGLEE EDGNGYVMPD THLRGTSSSR EGTLSSVGLS SVLGTEEEDE DEEYEYMNRK RRGSPARPPR PGSLEELGYE YMDVGSDLSA SLGSTQSCPL HPMAIVPSAG TTPDEDYEYM NRRRGAGGSG GDYAAMGACP AAEQGYEEMR AFQGPGHQAP HVRYARLKTL RSLEATDSAF DNPDYWHSRL FPKANAQRI //